- Home
- AIMD vs BFRI Comparison
AIMD vs BFRI Comparison
Compare AIMD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- BFRI
- Stock Information
- Founded
- AIMD 1984
- BFRI 1997
- Country
- AIMD United States
- BFRI United States
- Employees
- AIMD N/A
- BFRI N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- AIMD Health Care
- BFRI Health Care
- Exchange
- AIMD Nasdaq
- BFRI Nasdaq
- Market Cap
- AIMD 6.0M
- BFRI 6.2M
- IPO Year
- AIMD N/A
- BFRI 2021
- Fundamental
- Price
- AIMD $0.46
- BFRI $0.97
- Analyst Decision
- AIMD
- BFRI Strong Buy
- Analyst Count
- AIMD 0
- BFRI 1
- Target Price
- AIMD N/A
- BFRI $7.00
- AVG Volume (30 Days)
- AIMD 132.1K
- BFRI 1.4M
- Earning Date
- AIMD 11-06-2024
- BFRI 11-13-2024
- Dividend Yield
- AIMD N/A
- BFRI N/A
- EPS Growth
- AIMD N/A
- BFRI N/A
- EPS
- AIMD N/A
- BFRI N/A
- Revenue
- AIMD $40,633.00
- BFRI $35,358,000.00
- Revenue This Year
- AIMD N/A
- BFRI $17.69
- Revenue Next Year
- AIMD N/A
- BFRI $19.71
- P/E Ratio
- AIMD N/A
- BFRI N/A
- Revenue Growth
- AIMD N/A
- BFRI 5.17
- 52 Week Low
- AIMD $0.40
- BFRI $0.61
- 52 Week High
- AIMD $4.29
- BFRI $4.00
- Technical
- Relative Strength Index (RSI)
- AIMD 49.75
- BFRI 48.79
- Support Level
- AIMD $0.42
- BFRI $0.94
- Resistance Level
- AIMD $0.48
- BFRI $1.25
- Average True Range (ATR)
- AIMD 0.04
- BFRI 0.14
- MACD
- AIMD 0.00
- BFRI -0.00
- Stochastic Oscillator
- AIMD 36.48
- BFRI 30.25
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.